Algert Global’s Boston Scientific BSX Stock Holding History

Algert Global’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$386K	Buy	6,156 +220	+4%	+$17.6K	0.01%	994
2025 Q4	$566K	Buy	+5,936	New	+$582K	0.01%	932
2025 Q3	–	Sell	-13,086	Closed	-$1.41M	–	1148
2025 Q2	$1.41M	Buy	13,086 +11,086	+554%	+$1.12M	0.03%	731
2025 Q1	$202K	Sell	2,000 -1,330	-40%	-$134K	0.01%	1085
2024 Q4	$297K	Buy	+3,330	New	+$293K	0.01%	992
2017 Q1	–	Sell	-69,547	Closed	-$1.5M	–	319
2016 Q4	$1.5M	Buy	69,547 +19,403	+39%	+$423K	0.43%	81
2016 Q3	$1.19M	Buy	+50,144	New	+$1.2M	0.35%	108
2014 Q1	–	Sell	-142,830	Closed	-$1.72M	–	321
2013 Q4	$1.72M	Sell	142,830 -380	-0.3%	-$4.49K	0.46%	75
2013 Q3	$1.68M	Sell	143,210 -323,200	-69%	-$3.5M	0.48%	66
2013 Q2	$4.32M	Buy	+466,410	New	+$3.96M	1.34%	4

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Algert Global's BSX Position: Q1 2026 in Review

Algert Global increased its Boston Scientific (BSX) stake by 3.7% in Q1 2026, buying an estimated $17.6K and bringing the position to 6,156 shares worth $386K. The position accounts for 0.01% of the portfolio, ranked #994.

Algert Global first reported a position in BSX in Q2 2013 and has held it in 10 quarters since. The position peaked at $4.32M in Q2 2013. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Algert Global held 6,156 shares of Boston Scientific worth $386K as of Q1 2026.
Algert Global bought 220 Boston Scientific shares in Q1 2026, an estimated $17.6K.
Boston Scientific made up 0.01% of Algert Global's portfolio in Q1 2026, its #994 holding.
Algert Global first reported a position in Boston Scientific in Q2 2013 and has held it in 10 quarters since.
Algert Global's Boston Scientific position peaked at $4.32M in Q2 2013.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.